![](https://investorshub.advfn.com/uicon/138434.png?cb=1464725830)
Thursday, September 02, 2021 4:00:20 PM
Also, the Pfizer study on PF-07321332/Ritonavir shows on the clinicaltrials.gov site (updated August 23) as not yet recruiting. It also shows an estimated primary completion date of October 18, 2021 and an estimated study completion date of February 28, 2022.
So the primary and final completion is oct 31 on the trials page? You guys starting to get a hint at how stupid this guy is. Like for real? You say in the recent interview end of q4? And now you adjust the completion date to oct 31? This is incompetence . MF you need a marketing team , stop opening your mouth . Makes me so mad knowing pfizer and Merck are working overtime to get their trials done before us and our ceo is spending his extra time sitting with has hands under his rear end playing golf and not focusing on getting this trial done. Couldn’t make it as a phase 3, couldn’t even make it as a shroom play . Utter fool at the helm of rvv
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM